Close Menu

NEW YORK — Australian molecular diagnostics developer Genetic Technologies said last week that it received a notice that it is out of compliance with the Nasdaq's continued listing requirements and its shares face delisting.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.